Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarkers for Immunotherapy: Current Developments and Challenges.
Spencer KR, Wang J, Silk AW, Ganesan S, Kaufman HL, Mehnert JM. Spencer KR, et al. Among authors: kaufman hl. Am Soc Clin Oncol Educ Book. 2016;35:e493-503. doi: 10.1200/EDBK_160766. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249758 Free article.
Oncolytic virus immunotherapy for melanoma.
Dharmadhikari N, Mehnert JM, Kaufman HL. Dharmadhikari N, et al. Among authors: kaufman hl. Curr Treat Options Oncol. 2015 Mar;16(3):326. doi: 10.1007/s11864-014-0326-0. Curr Treat Options Oncol. 2015. PMID: 25777572 Review.
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer.
Stein MN, Hussain M, Stadler WM, Liu G, Tereshchenko IV, Goodin S, Jeyamohan C, Kaufman HL, Mehnert J, DiPaola RS. Stein MN, et al. Among authors: kaufman hl. Clin Genitourin Cancer. 2016 Feb;14(1):22-7. doi: 10.1016/j.clgc.2015.09.010. Epub 2015 Sep 21. Clin Genitourin Cancer. 2016. PMID: 26476589 Free PMC article. Clinical Trial.
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
Johnson DB, Sullivan RJ, Ott PA, Carlino MS, Khushalani NI, Ye F, Guminski A, Puzanov I, Lawrence DP, Buchbinder EI, Mudigonda T, Spencer K, Bender C, Lee J, Kaufman HL, Menzies AM, Hassel JC, Mehnert JM, Sosman JA, Long GV, Clark JI. Johnson DB, et al. Among authors: kaufman hl. JAMA Oncol. 2016 Feb;2(2):234-40. doi: 10.1001/jamaoncol.2015.4368. JAMA Oncol. 2016. PMID: 26633184
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.
Mehnert JM, Panda A, Zhong H, Hirshfield K, Damare S, Lane K, Sokol L, Stein MN, Rodriguez-Rodriquez L, Kaufman HL, Ali S, Ross JS, Pavlick DC, Bhanot G, White EP, DiPaola RS, Lovell A, Cheng J, Ganesan S. Mehnert JM, et al. Among authors: kaufman hl. J Clin Invest. 2016 Jun 1;126(6):2334-40. doi: 10.1172/JCI84940. Epub 2016 May 9. J Clin Invest. 2016. PMID: 27159395 Free PMC article.
IFN-λ cancer immunotherapy: new kid on the block.
Lasfar A, Gogas H, Zloza A, Kaufman HL, Kirkwood JM. Lasfar A, et al. Among authors: kaufman hl. Immunotherapy. 2016 Jul;8(8):877-88. doi: 10.2217/imt-2015-0021. Immunotherapy. 2016. PMID: 27381684 Free PMC article. Review.
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Linette GP, Milella M, Brownell I, Lewis KD, Lorch JH, Chin K, Mahnke L, von Heydebreck A, Cuillerot JM, Nghiem P. Kaufman HL, et al. Lancet Oncol. 2016 Oct;17(10):1374-1385. doi: 10.1016/S1470-2045(16)30364-3. Epub 2016 Sep 1. Lancet Oncol. 2016. PMID: 27592805 Free PMC article. Clinical Trial.
242 results